Psychopharmacology news.
Silva
Raul R
RR
D000662:Amphetamines / Q000009:adverse effects / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects; D001569:Benzodiazepines / Q000009:adverse effects; D002170:Canada; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000627:therapeutic use; D017332:Cetirizine / Q000009:adverse effects; D004340:Drug Contamination; D004347:Drug Interactions; D006634:Histamine H1 Antagonists / Q000009:adverse effects; D006801:Humans; D008774:Methylphenidate / Q000009:adverse effects; D000077152:Olanzapine; D011600:Psychopharmacology
C090411:Adderall; D000662:Amphetamines; D014150:Antipsychotic Agents; D000697:Central Nervous System Stimulants; D006634:Histamine H1 Antagonists; D001569:Benzodiazepines; D008774:Methylphenidate; D000077152:Olanzapine; D017332:Cetirizine